COI.
search Request for Consideration arrow_forward menu
close Submit Innovation
close
92
Sunnyvale, USA Series B

IoMT Risk Remediation & Analytics

Asimily • Led by Shankar Somasundaram

🔒 Confidential
COI SCORE 92 VERIFIED

🔬 The Innovation Core

The Pain Point

Healthcare organizations (HDOs) face millions of vulnerabilities in connected medical devices (IoMT). They cannot patch them due to FDA regulations or warranty risks, leading to 'alert fatigue' where 98% of flagged risks are unfixable.

The Solution

A vertical-specific risk management platform that uses Deep Packet Inspection (DPI) to analyze medical protocols. It identifies the specific 2% of vulnerabilities that are actually exploitable in a clinical environment and simulates attacks to prioritize fixes.

⚡ Verified Impact

● Validated
-90% (Filters non-exploitable CVEs)Alert Reduction
+85% (Case Study Validated)Remediation Efficiency
100% Passive VisibilityDevice Coverage
#11 in Cyber (Deloitte Fast 500)Fastest Growing
CERTIFICATION

Gold Standard

TRL 9/9

📊 Market Traction

Revenue History ($M)

Market Share

🧠 Analyst Verdict: Niche Leader

"Asimily has carved a defensible moat in the healthcare sector by focusing on clinical context rather than just IT asset management. While competitors like Armis offer broader scope, Asimily's proprietary 'Risk Simulator' effectively solves the hospital operational bottleneck by proving which vulnerabilities can be safely ignored."

✅ Pros

  • Precision Focus: Specialized deeply in medical protocols (DICOM/HL7) allowing for passive scanning without crashing sensitive devices.
  • Risk Simulation: Unique capability to forecast 'what-if' attack scenarios to justify inaction on non-critical bugs.
  • High ROI: Proven to reduce required patch workload by ~85% (Methodist Le Bonheur Case Study).

⚠️ Risks

  • Scale Limits: Highly specialized focus limits TAM compared to cross-sector rivals (Armis/Claroty).
  • Market Noise: The space is crowded with 'med-tech' security features from larger firewalls (Palo Alto).
  • Integration Heavy: Full value requires deep integration into legacy hospital network segmentation.

🛠️ Use Cases

💡
Clinical Risk Prioritization

Filters out 98% of non-critical alerts to focus on patient safety.

💡
Forensic Incident Response

Captures packet data to reconstruct attacks on medical devices.

💡
Procurement Risk Analysis

Predicts device lifecycle risks before purchase.

Market Maturity

Stop Guessing.
Know What's Deployable.

Marketing brochures look the same for TRL-3 (Concept) and TRL-9 (Proven) tech. Our radar cuts through the noise, showing you exactly if this innovation has crossed the "Pilot-to-Production" chasm.

9

Commercial Grade

Fully audited operational history. Ready for scale.

6

Prototype / Pilot

Functional in relevant environments. High risk, high reward.

Current Maturity Status

TRL Score 9.0 / 9.0
  • check_circle Technology validated in lab (TRL 4)
  • check_circle System prototype demonstration (TRL 7)
  • check_circle Actual system proven in operations (TRL 9)
Transparency

Forensic Evidence Chain

We don't just "approve" listings. We build a permanent, immutable audit trail for every verified claim. See exactly what was checked, when, and by whom.

View Sample Audit Report →

Technical Diligence

> Architecture Review: PASS
> Security Audit: ISO 27001
> Scalability Test: 10k TPS

Customer Verification

> Client Interview: #8821
> Deployment Status: LIVE
> ROI Confirmed: 18% Savings

Certification Issued

STATUS: VERIFIED verified

Enterprise Action Center

Select the engagement model that fits your business needs.

🚀
Launch Pilot / POC
Submit your problem statement and request a proof of concept scope.
💡
Propose Use Case
Have a new application for this tech? Submit a use case for review.
⭐
Submit Review
Already using this solution? Verify impact and submit your CSAT score.
🛡️
Request Due Diligence
Access compliance certs, security audits, and financial health reports.

Secure Premium Access

Complete to proceed with your request